NTRA 157.38 (+0.46%)
US6323071042• Medical Diagnostics & Research• Diagnostics & Research
Intro Numbers Peers
  1. Home
  2. /
  3. All Stocks
  4. /
  5. NTRA

Natera (NTRA) Competitor Comparison

We are evaluating the key criteria listed to compare Natera (NTRA) against its competitors in the Diagnostics & Research industry.

Market Capitalization

18 / 58

Gross Profits

25 / 52

Total Revenue

23 / 57

EBITDA

56 / 56

Free Cashflow

54 / 56

Quick Ratio

18 / 57

Earnings per Share

43 / 56

Dividend yield

0 / 9

Total Cash

8 / 57

Performance 3 years

1 / 58

Performance 5 years

2 / 58

Performance 10 years

4 / 58

Linearity 3 years

58 / 58

Linearity 5 years

57 / 58

Linearity 10 years

55 / 58

Total Rank

24 / 58

Dividend Rank

23 / 58

Valuation Rank

44 / 58

Piotroski Rank

34 / 58

Muliplier Rank

57 / 58

Linearity 10 years - NTRA ranking 55 / 58

These are the competitors of Natera in the industry Diagnostics & Research ranked by linearity 10 years
1. Inotiv NOTV
107.42
2. National Research NRC
49.31
3. Ortho Clinical Diagnostics Holdings OCDX
33.4
4. Anixa Biosciences ANIX
24.28
5. NeoGenomics NEO
12.53
6. Olink Holding OLK
8.11
7. Guardant Health GH
7.88
8. Neogen NEOG
6.25
9. Charles River Laboratories CRL
6.12
10. Global Cord Blood CO
5.67
11. Illumina ILMN
5.12
12. DarioHealth DRIO
4.86
13. Pacific Biosciences of California PACB
4.49
14. Fulgent Genetics FLGT
4.12
15. Syneos Health SYNH
3.71
16. Qiagen QGEN
3.56
17. CareDx CDNA
3.46
18. Icon ICLR
3.43
19. Sotera Health SHC
3.35
20. Co-Diagnostics CODX
3.21
21. Exact Sciences EXAS
3.1
22. Enzo Biochem ENZ
3.08
23. Twist Bioscience TWST
3.03
24. Myriad Genetics MYGN
3
25. Bioventus BVS
2.74
26. Psychemedics PMD
2.57
27. IQVIA Holdings IQV
2.56
28. Exagen XGN
2.51
29. Sera Prognostics SERA
2.3
30. Aspira Womens Health AWH
2.28
31. Meridian Bioscience VIVO
2.1
32. MDxHealth MDXH
1.91
33. bioAffinity Technologies BIAF
1.9
34. Agilent Technologies A
1.9
35. Biodesix BDSX
1.87
36. Personalis PSNL
1.81
37. MaxCyte MXCT
1.8
38. Prenetics Global PRE
1.71
39. Organovo Holdings ONVO
1.66
40. Neuronetics STIM
1.62
41. Trinity Biotech TRIB
1.57
42. Thermo Fisher Scientific TMO
1.5
43. SeqLL SQL
1.42
44. Mettler-Toledo MTD
1.37
45. Interpace Biosciences IDXG
1.33
46. Laboratory Corp of America Holdings LH
1.32
47. Waters WAT
1.24
48. Danaher DHR
1.24
49. Quest Diagnostics DGX
1.15
50. PerkinElmer PKI
1.15
51. Precipio PRPO
1.09
52. DexCom DXCM
1.07
53. IDEXX Laboratories IDXX
0.58
54. Heska HSKA
0.52
55. Natera NTRA
0.4
56. Lantheus Holdings LNTH
0.34
57. RadNet RDNT
0.28
58. Medpace Holdings MEDP
0.25
Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.